Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

2.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.6K
CRISPR01:59

CRISPR

59.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
59.1K
CRISPR01:59

CRISPR

18.9K
18.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive assessment of on- and off-target mutagenesis via lipid nanoparticle delivery of CRISPR-Cas9 genome editing.

Molecular therapy. Nucleic acids·2026
Same author

AMPK-p38 axis converts human pluripotent stem cells to naive state.

iScience·2026
Same author

Impact of lipid-rich plaques in the femoropopliteal artery on limb outcomes in patients undergoing endovascular therapy.

Vascular medicine (London, England)·2026
Same author

Digital spatial profiling reveals additive effects of triple therapy on tumor microenvironment: anti-PD-L1, anti-VEGF, and PARP inhibition in mouse models.

Cancer immunology, immunotherapy : CII·2026
Same author

Trends in anticholinergic drug exposure and associated risk factors in older Australian patients with dementia.

Journal of psychiatric research·2026
Same author

Detailed analysis of postoperative complications and oncological outcomes in pelvic exenteration: A propensity score weighted analysis based on Japanese multicenter cohort study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same journal

An accessible, absorbance-based plate reader assay to assess cumulative exposure of blood plasma & serum to thawed conditions.

Methods (San Diego, Calif.)·2026
Same journal

EC-isHCR: A rapid method for in situ hybridization chain reaction in diverse animal samples.

Methods (San Diego, Calif.)·2026
Same journal

Single-Molecule methods to investigate mechanisms of transcription by RNA polymerase of Mycobacterium tuberculosis.

Methods (San Diego, Calif.)·2026
Same journal

Detection and sequencing of Usutu virus during mosquito surveillance: Use of multiple assays and techniques for identification at low levels.

Methods (San Diego, Calif.)·2026
Same journal

Experimental validation of an AI-driven digital healthcare platform for oral health behavior and plaque assessment among vietnamese children.

Methods (San Diego, Calif.)·2026
Same journal

Zeta potential: An efficient and cost-effective alternative for investigating cell-surface interactions.

Methods (San Diego, Calif.)·2026
See all related articles

Related Experiment Video

Updated: Mar 30, 2026

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
09:04

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Published on: September 25, 2019

8.9K

Efficient genomic correction methods in human iPS cells using CRISPR-Cas9 system.

Hongmei Lisa Li1, Peter Gee1, Kentaro Ishida2

  • 1Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.

Methods (San Diego, Calif.)
|November 4, 2015
PubMed
Summary
This summary is machine-generated.

This review details CRISPR-Cas9 gene editing in human induced pluripotent stem cells (iPSCs), focusing on effective genomic sequence modification for research and therapy. It highlights critical steps for successful gene correction in iPSCs.

Keywords:
CRISPRGene correctionGenome editingKnock-inKnock-outiPS cells

More Related Videos

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
09:03

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Published on: May 10, 2020

4.7K
CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions
04:21

CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions

Published on: November 1, 2024

1.4K

Related Experiment Videos

Last Updated: Mar 30, 2026

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
09:04

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Published on: September 25, 2019

8.9K
Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
09:03

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Published on: May 10, 2020

4.7K
CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions
04:21

CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions

Published on: November 1, 2024

1.4K

Area of Science:

  • Biotechnology
  • Genetics
  • Stem Cell Biology

Background:

  • Human induced pluripotent stem cells (iPSCs) are crucial for disease modeling and gene therapy.
  • CRISPR-Cas9 technology offers precise gene editing capabilities.
  • Effective genome editing in iPSCs is essential for advancing regenerative medicine.

Purpose of the Study:

  • To review methods for effective genomic sequence editing in iPSCs.
  • To share experiences in correcting dystrophin gene mutations using CRISPR-Cas9 in iPSCs.
  • To provide guidance for researchers performing genome editing in iPSCs.

Main Methods:

  • CRISPR-Cas9 system for gene editing.
  • Design of specific single-guide RNAs (sgRNAs).
  • Efficient transfection methods for iPSCs.
  • Detection assays for genomic cleavage activity.
  • Step-by-step cell recovery protocols for iPSCs.

Main Results:

  • Successful correction of dystrophin gene mutations in iPSCs.
  • Identification of critical factors for successful iPSC genome editing (sgRNA design, transfection, detection).
  • Demonstration of the importance of careful cell handling during recovery.

Conclusions:

  • CRISPR-Cas9 is a powerful tool for precise gene editing in iPSCs.
  • Optimized sgRNA design, transfection, and detection are key to successful iPSC genome editing.
  • Careful handling and recovery protocols are vital for obtaining sufficient edited iPSC clones.